-+ 0.00%
-+ 0.00%
-+ 0.00%

CREATIVE MEDICAL TECHNOLOGY HOLDINGS EXPANDS ADAPT TRIAL UNDER NEW FDA CLEARANCE AND RAPIDLY ADVANCES TOWARD PHASE 3 PLANNING FOR OLASTROCEL IN CHRONIC LOWER BACK PAIN

Reuters·06/22/2026 13:15:00

Please log in to view news